RESUMEN
The significant variability in the clinical manifestations of COL2A1-associated skeletal dysplasias makes it necessary to conduct a clinical and genetic analysis of individual nosological variants, which will contribute to improving our understanding of the pathogenetic mechanisms and prognosis. We presented the clinical and genetic characteristics of 60 Russian pediatric patients with type II collagenopathies caused by previously described and newly identified variants in the COL2A1 gene. Diagnosis confirmation was carried out by new generation sequencing of the target panel with subsequent validation of the identified variants using automated Sanger sequencing. It has been shown that clinical forms of spondyloepiphyseal dysplasias predominate in childhood, both with more severe clinical manifestations (58%) and with unusual phenotypes of mild forms with normal growth (25%). However, Stickler syndrome, type I was less common (17%). In the COL2A1 gene, 28 novel variants were identified, and a total of 63% of the variants were found in the triple helix region resulted in glycine substitution in Gly-XY repeats, which were identified in patients with clinical manifestations of congenital spondyloepiphyseal dysplasia with varying severity, and were not found in Stickler syndrome, type I and Kniest dysplasia. In the C-propeptide region, five novel variants leading to the development of unusual phenotypes of spondyloepiphyseal dysplasia have been identified.
Asunto(s)
Fisura del Paladar/patología , Enfermedades del Colágeno/patología , Colágeno Tipo II/genética , Enanismo/patología , Cara/anomalías , Enfermedad de la Membrana Hialina/patología , Mutación , Osteocondrodisplasias/congénito , Osteocondrodisplasias/patología , Adolescente , Niño , Preescolar , Fisura del Paladar/epidemiología , Fisura del Paladar/genética , Enfermedades del Colágeno/epidemiología , Enfermedades del Colágeno/genética , Enanismo/epidemiología , Enanismo/genética , Cara/patología , Femenino , Humanos , Enfermedad de la Membrana Hialina/epidemiología , Enfermedad de la Membrana Hialina/genética , Lactante , Masculino , Osteocondrodisplasias/epidemiología , Osteocondrodisplasias/genética , Fenotipo , Federación de Rusia/epidemiologíaRESUMEN
The importance of the early diagnosis and treatment of diabetes and its cutaneous complications has become increasingly recognized. When diabetic non-injured skin was stained with Masson's trichrome, its dermal collagen was found to be disordered, its density was variable, and it was dispersed or arranged in vague fascicles. The collagen type I sequencing results of RNA sequencing-based transcriptome analysis of three primary human skin cell types-dermal fibroblasts, dermal microvascular endothelial cells, and epidermal keratinocytes-under high glucose were analyzed. The results showed that both COL1A1 and COL1A2 mRNA expressions were reduced in human dermal fibroblasts (HDFs). The ratio of matrix metalloproteinase (MMP)-2/tissue inhibitors of metalloproteinase (TIMP)-2 and MMP-9/TIMP-1 in HDFs increased when treated with high glucose. By inhibiting MMP-2 and MMP-9 with SB-3CT, collagen deposition disorder of the skin in streptozotocin-induced diabetes mice was alleviated. The imbalance of MMP2/TIMP2 and MMP9/TIMP1 contributes to the non-injured skin disorder of collagen deposition in diabetes, suggesting a possibility for early treatment of diabetes skin complications.
Asunto(s)
Enfermedades del Colágeno/etiología , Colagenasas/genética , Diabetes Mellitus Experimental/complicaciones , Piel/patología , Inhibidores Tisulares de Metaloproteinasas/genética , Animales , Células Cultivadas , Colágeno/efectos de los fármacos , Colágeno/genética , Colágeno/metabolismo , Enfermedades del Colágeno/genética , Enfermedades del Colágeno/metabolismo , Enfermedades del Colágeno/patología , Colagenasas/metabolismo , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Fibroblastos/patología , Expresión Génica/efectos de los fármacos , Glucosa/farmacología , Humanos , Masculino , Metaloproteinasa 2 de la Matriz/genética , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/genética , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Ratones Endogámicos C57BL , Piel/metabolismo , Estreptozocina , Inhibidor Tisular de Metaloproteinasa-1/genética , Inhibidor Tisular de Metaloproteinasa-1/metabolismo , Inhibidor Tisular de Metaloproteinasa-2/genética , Inhibidor Tisular de Metaloproteinasa-2/metabolismo , Inhibidores Tisulares de Metaloproteinasas/metabolismoRESUMEN
Monogenic syndromic disorders frequently feature ocular manifestations, one of which is glaucoma. In many cases, glaucoma in children may go undetected, especially in those that have other severe systemic conditions that affect other parts of the eye and the body. Similarly, glaucoma may be the first presenting sign of a systemic syndrome. Awareness of syndromes associated with glaucoma is thus critical both for medical geneticists and ophthalmologists. In this review, we highlight six categories of disorders that feature glaucoma and other ocular or systemic manifestations: anterior segment dysgenesis syndromes, aniridia, metabolic disorders, collagen/vascular disorders, immunogenetic disorders, and nanophthalmos. The genetics, ocular and systemic features, and current and future treatment strategies are discussed. Findings from rare diseases also uncover important genes and pathways that may be involved in more common forms of glaucoma, and potential novel therapeutic strategies to target these pathways.
Asunto(s)
Enfermedades Hereditarias del Ojo/genética , Glaucoma/etiología , Glaucoma/genética , Aniridia/genética , Aniridia/patología , Enfermedades del Colágeno/complicaciones , Enfermedades del Colágeno/genética , Enfermedades del Colágeno/patología , Anomalías del Ojo/genética , Anomalías del Ojo/patología , Enfermedades Hereditarias del Ojo/patología , Glaucoma/patología , Glaucoma de Ángulo Cerrado/complicaciones , Glaucoma de Ángulo Cerrado/genética , Glaucoma de Ángulo Cerrado/patología , Humanos , Hiperopía/complicaciones , Hiperopía/genética , Hiperopía/patología , Enfermedades del Sistema Inmune/complicaciones , Enfermedades del Sistema Inmune/genética , Enfermedades del Sistema Inmune/patología , Enfermedades Metabólicas/complicaciones , Enfermedades Metabólicas/genética , Enfermedades Metabólicas/patología , Microftalmía/complicaciones , Microftalmía/genética , Microftalmía/patología , Síndrome , Enfermedades Vasculares/complicaciones , Enfermedades Vasculares/genética , Enfermedades Vasculares/patologíaRESUMEN
COL2A1-related disorders represent a heterogeneous group of skeletal dysplasias with a wide phenotypic spectrum. Our aim is to characterize the clinical and molecular phenotypes of Chinese patients with COL2A1-related dysplasia and to explore their phenotype-genotype relations. Clinical data were collected, physical examinations were conducted, and X-ray radiography and genetic analyses were performed in ten families involving 29 patients with COL2A1-related dysplasia. Nine mutations were identified in COL2A1, including five novel (c.816+6C>T, p.Gly246Arg, p.Gly678Glu, p.Gly1014Val and p.Ter1488Gln) and four reported previously (p.Gly204Val, p.Arg275Cys, p.Gly504Ser and p.Arg719Cys). Based on clinical features and molecular mutations, the ten families were classified into five definite COL2A1-related disorders: four families with spondyloepiphyseal dysplasia congenita (SEDC), three with osteoarthritis with mild chondrodysplasia (OSCPD), one with Czech dysplasia, one with Kniest dysplasia, and one with epiphyseal dysplasia, multiple, with myopia and deafness (EDMMD). Based on genetic testing results, prenatal diagnosis and genetic counseling were accomplished for one female proband with OSCDP. Chinese patients with OSCDP, Czech dysplasia and EDMMD caused by COL2A1 mutations were first reported, expanding the spectrum of COL2A1 mutations and the phenotype of COL2A1-related disorders and providing further evidence for the phenotype-genotype relations, which may help improve procreative management of COL2A1-related disorders.
Asunto(s)
Colágeno Tipo II/genética , Osteoartritis/genética , Osteocondrodisplasias/congénito , Adolescente , Adulto , Anciano , Pueblo Asiatico , Niño , Preescolar , Fisura del Paladar/genética , Enfermedades del Colágeno/genética , Enanismo/genética , Cara/anomalías , Femenino , Genotipo , Humanos , Enfermedad de la Membrana Hialina/genética , Masculino , Persona de Mediana Edad , Mutación/genética , Osteocondrodisplasias/genética , Fenotipo , Dedos del Pie/anomalías , Adulto JovenRESUMEN
BACKGROUND: Friesian horses are known for their high inbreeding rate resulting in several genetic diseases such as hydrocephaly and dwarfism. This last decade, several studies focused on two other presumed hereditary traits in Friesian horses: megaoesophagus and aortic rupture. The pathogenesis of these diseases remains obscure but an important role of collagen has been hypothesized. The purpose of this study was to examine possible breed-related differences in collagen catabolism. Urinary specimens from Friesian (n = 17, median age 10 years old) and Warmblood horses (n = 17, median age 10 years old) were assessed for mature collagen cross-links, i.e. pyridinoline (PYD) (=hydroxylysylpyridinoline/HP) and deoxypyridinoline (DPD) (lysylpyridinoline /LP). Solid-phase extraction was performed, followed by reversed-phase ion-paired liquid chromatography prior to tandem mass spectrometry (MS/MS) detection. RESULTS: Mean urinary concentrations of free PYD, expressed as fPYD/creatinine ratio, were significantly higher in Friesian horses compared to Warmblood horses (28.5 ± 5.2 versus 22.2 ± 9.6 nmol/mmol, p = 0.02) while mean fDPD/creatinine ratios were similar in both horse breeds (3.0 ± 0.7 versus 4.6 ± 3.7 nmol/mmol, p = 0.09). CONCLUSIONS: Since DPD is considered a specific bone degradation marker and PYD is more widely distributed in connective tissues, the significant elevation in the mean PYD/DPD ratio in Friesian versus Warmblood horses (9.6 ± 1.6 versus 5.7 ± 1.8, p < 0.0001) suggests a soft tissue origin for the increased fPYD levels. Considering that a previous study found no differences in total collagen content between Friesian and Warmblood horses for tendon and aortic tissue, this indicates a higher rate of collagen degradation. The latter might, at least in part, explain the predisposition of Friesians to connective tissue disorders.
Asunto(s)
Aminoácidos/orina , Enfermedades del Colágeno/veterinaria , Colágeno/metabolismo , Enfermedades de los Caballos/orina , Animales , Enfermedades del Colágeno/genética , Enfermedades del Colágeno/orina , Femenino , Enfermedades de los Caballos/genética , Enfermedades de los Caballos/metabolismo , Caballos , Endogamia , Masculino , Especificidad de la EspecieRESUMEN
Achieving confidence in the causality of a disease locus is a complex task that often requires supporting data from both statistical genetics and clinical genomics. Here we describe a combined approach to identify and characterize a genetic disorder that leverages distantly related patients in a health system and population-scale mapping. We utilize genomic data to uncover components of distant pedigrees, in the absence of recorded pedigree information, in the multi-ethnic BioMe biobank in New York City. By linking to medical records, we discover a locus associated with both elevated genetic relatedness and extreme short stature. We link the gene, COL27A1, with a little-known genetic disease, previously thought to be rare and recessive. We demonstrate that disease manifests in both heterozygotes and homozygotes, indicating a common collagen disorder impacting up to 2% of individuals of Puerto Rican ancestry, leading to a better understanding of the continuum of complex and Mendelian disease.
Asunto(s)
Enfermedades del Colágeno/epidemiología , Enfermedades del Colágeno/genética , Colágenos Fibrilares/genética , Epidemiología Molecular , Linaje , Adolescente , Adulto , Anciano , Niño , Femenino , Genotipo , Heterocigoto , Hispánicos o Latinos , Homocigoto , Humanos , Masculino , Persona de Mediana Edad , Familia de Multigenes , Enfermedades Musculoesqueléticas/epidemiología , Enfermedades Musculoesqueléticas/genética , Ciudad de Nueva York/epidemiología , Ciudad de Nueva York/etnología , Secuenciación Completa del Genoma , Adulto JovenRESUMEN
BACKGROUND: Acquired reactive perforating collagenosis (ARPC) is a rare skin disorder characterized by transepidermal elimination of dermal collagen. There is little data regarding the pathogenesis of ARPC. The receptor for advanced glycation end products (RAGE) is a multiligand transmembrane receptor that plays an important role in inflammatory responses and may be involved in the pathogenesis of ARPC. AIM: To explore the expression of RAGE in ARPC. METHODS: Paraffin-embedded punch biopsy specimens of 41 patients with ARPC and of 11 healthy controls with normal skin were obtained from the Department Of Pathology. Clinical data of all patients were reviewed from the medical files. All specimens were stained immunohistochemically with antibody to RAGE (Anti-RAGE). The intensity of RAGE expression was assessed semi-quantitatively on epidermal cells, microvascular endothelium, dermal fibroblasts and inflammatory cells and graded as 0 (no staining), 1 (weak), 2 (moderate) and 3 (strong). The patients were divided into diabetic and nondiabetic groups for analysis. RESULTS: RAGE expression in microvascular endothelium, inflammatory cells and fibroblasts of patients with ARPC was more intense than normal tissues of healthy participants (P values are 0.005, 0.017 and P > 0.05). LIMITATIONS: Our method of assessment of RAGE expression was semi-quantitative. CONCLUSION: We observed an overexpression of RAGE in lesional samples of patients with ARPC which was independent of the presence of diabetes.
Asunto(s)
Enfermedades del Colágeno/diagnóstico , Enfermedades del Colágeno/metabolismo , Receptor para Productos Finales de Glicación Avanzada/biosíntesis , Adulto , Anciano , Antígenos de Neoplasias/biosíntesis , Antígenos de Neoplasias/genética , Enfermedades del Colágeno/genética , Femenino , Expresión Génica , Humanos , Masculino , Persona de Mediana Edad , Proteínas Quinasas Activadas por Mitógenos/biosíntesis , Proteínas Quinasas Activadas por Mitógenos/genética , Receptor para Productos Finales de Glicación Avanzada/genéticaAsunto(s)
Angiofibroma/diagnóstico , Enfermedades del Colágeno/diagnóstico , Síndromes Neoplásicos Hereditarios/diagnóstico , Proteínas Proto-Oncogénicas/genética , Neoplasias Cutáneas/diagnóstico , Adulto , Angiofibroma/genética , Angiofibroma/patología , Biopsia , Enfermedades del Colágeno/genética , Enfermedades del Colágeno/patología , Eritema/etiología , Dermatosis Facial/etiología , Neoplasias Faciales/genética , Neoplasias Faciales/patología , Femenino , Genes Dominantes , Humanos , Hiperparatiroidismo Primario/sangre , Hiperparatiroidismo Primario/genética , Síndromes Neoplásicos Hereditarios/genética , Síndromes Neoplásicos Hereditarios/patología , Hormona Paratiroidea/sangre , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/patología , TorsoRESUMEN
A rigidez da parede venosa pode aumentar em síndromes em que há uma redução da quantidade de elastina, ocasionando malformações venosas mesmo em indivíduos que possuem mosaicismo para tais síndromes. Casos com apresentação de afecções colagenosas em áreas delimitadas não foram descritos na literatura. O paciente apresentava lesão bem delimitada em região anteromedial da coxa com aumento de elasticidade e presença de vasos tortuosos apenas no local da lesão, não apresentando nenhuma síndrome colagenosa. Foi realizada uma biópsia que evidenciou alterações em relação ao padrão das fibras elásticas e proliferação de vasos sanguíneos. A malformação venosa foi tratada satisfatoriamente com embolização. As doenças do colágeno causam hiperextensibilidade cutânea, o que provoca flacidez e propicia traumas. As colagenoses bem delimitadas são raras, pois geralmente esse grupo de doenças envolve acometimento sistêmico. As malformações vasculares podem ocorrer em diversas doenças do colágeno, mas de forma generalizada e não localizada, e uma explicação para isso seria o mosaicismo genético.
In syndromes that involve reduced quantities of elastin, the rigidity of vein walls may be increased, causing venous malformations, even in people who have mosaicism for these syndromes. There are no previous descriptions in the literature of collagen diseases presenting in specific, delimited areas. The patient described here presented with a lesion restricted to a well-defined area of the anteromedial thigh, in which elasticity was increased and vessels were tortuous, in the area of the lesion only, and with no other signs of collagen syndromes. A biopsy was conducted and the findings included changes to the normal arrangement of the elastic fibers and proliferation of blood vessels. The venous malformation was treated satisfactorily by embolization. Collagen diseases can cause cutaneous hyperextensibility, provoking flaccidity and a propensity to traumatisms. Connective tissue diseases restricted to well-delimited areas are rare, since this group of diseases usually has systemic involvement. Vascular malformations can be seen in many different collagen diseases, but with generalized rather than localized presentation. One possible explanation for the case described here is genetic mosaicism.
Asunto(s)
Humanos , Masculino , Adulto , Anomalías Cutáneas/diagnóstico , Anomalías Cutáneas/genética , Anomalías Cutáneas/patología , Enfermedades del Colágeno/congénito , Enfermedades del Colágeno/genética , Enfermedades del Colágeno/patología , Mosaicismo , Embolización Terapéutica/métodos , Malformaciones Vasculares/complicacionesRESUMEN
Heterozygous COL2A1 variants cause a wide spectrum of skeletal dysplasia termed type II collagenopathies. We assessed the impact of this gene in our French series. A decision tree was applied to select 136 probands (71 Stickler cases, 21 Spondyloepiphyseal dysplasia congenita cases, 11 Kniest dysplasia cases, and 34 other dysplasia cases) before molecular diagnosis by Sanger sequencing. We identified 66 different variants among the 71 positive patients. Among those patients, 18 belonged to multiplex families and 53 were sporadic. Most variants (38/44, 86%) were located in the triple helical domain of the collagen chain and glycine substitutions were mainly observed in severe phenotypes, whereas arginine to cysteine changes were more often encountered in moderate phenotypes. This series of skeletal dysplasia is one of the largest reported so far, adding 44 novel variants (15%) to published data. We have confirmed that about half of our Stickler patients (46%) carried a COL2A1 variant, and that the molecular spectrum was different across the phenotypes. To further address the question of genotype-phenotype correlation, we plan to screen our patients for other candidate genes using a targeted next-generation sequencing approach.
Asunto(s)
Sustitución de Aminoácidos , Artritis/genética , Enfermedades del Colágeno/genética , Colágeno Tipo II/genética , Enfermedades del Tejido Conjuntivo/genética , Pérdida Auditiva Sensorineural/genética , Osteocondrodisplasias/genética , Fenotipo , Desprendimiento de Retina/genética , Artritis/patología , Enfermedades del Colágeno/patología , Colágeno Tipo II/química , Enfermedades del Tejido Conjuntivo/patología , Femenino , Pérdida Auditiva Sensorineural/patología , Humanos , Masculino , Osteocondrodisplasias/patología , Linaje , Dominios Proteicos , Desprendimiento de Retina/patologíaRESUMEN
Constitutive COL2A1 mutations are associated with a wide variety of clinical manifestations known as type II collagenopathies. Among them is Kniest dysplasia, which is phenotypically variable and includes both skeletal (short trunk and limbs, kyphoscoliosis, prominent joints, and osteoarthritis) and craniofacial characteristics. Kniest dysplasia mutations primarily arise in the triple-helicoidal region of the alpha 1 (II) chain in COL2A1 between exons 12 and 24. Somatic COL2A1 mutations have been identified in chondrosarcoma, a rare cartilage forming neoplasm, with a hypermutability of the gene reported in 37% of cases. However, to the best of our knowledge, there is no reported increase in predisposition to chondrosarcoma in human collagenopathies, and no reported clinical association between these congenital diseases and cartilaginous tumors. In the case study presented here, we report the first description of an association between these two rare diseases involving COL2A1, in a child presenting with Kniest dysplasia and a grade I sphenoethmoidal chondrosarcoma. We also describe a new constitutive mutation in COL2A1.
Asunto(s)
Neoplasias Óseas/genética , Condrosarcoma/genética , Fisura del Paladar/genética , Enfermedades del Colágeno/genética , Colágeno Tipo II/genética , Enanismo/genética , Cara/anomalías , Enfermedad de la Membrana Hialina/genética , Mutación/genética , Osteocondrodisplasias/genética , Neoplasias Óseas/patología , Condrosarcoma/patología , Fisura del Paladar/patología , Enfermedades del Colágeno/patología , Enanismo/patología , Cara/patología , Humanos , Enfermedad de la Membrana Hialina/patología , Recién Nacido , Masculino , Osteocondrodisplasias/patología , PronósticoRESUMEN
OBJECTIVE: To detect potential mutation of COL2A1 gene in two children suspected for Kniest dysplasia. METHODS: The 54 exons and splicing regions of the COL2A1 gene were amplified with PCR and the product was subjected to direct sequencing. RESULTS: A missense mutation (c.905C>T, p.Ala302Val) was found in the coding region of the COL2A1 gene, which has been previously reported in abroad. The patients appeared to have short trunk dwarfism, enlarged joints and midface hypoplasia. CONCLUSION: The probands are the first cases of Kniest dysplasia described in China, and so was the p.Ala302Val mutation.
Asunto(s)
Fisura del Paladar/genética , Enfermedades del Colágeno/genética , Colágeno Tipo II/genética , Enanismo/genética , Cara/anomalías , Enfermedad de la Membrana Hialina/genética , Mutación Missense , Osteocondrodisplasias/genética , Secuencia de Bases , Preescolar , China , Exones , Humanos , Masculino , Datos de Secuencia Molecular , Sistemas de Lectura Abierta , Empalme del ARNAsunto(s)
Enfermedades del Colágeno/complicaciones , Colágeno Tipo III/análisis , Enfermedades Renales/complicaciones , Glomérulos Renales/química , Síndrome Nefrótico/etiología , Antihipertensivos/uso terapéutico , Enfermedades del Colágeno/diagnóstico , Enfermedades del Colágeno/genética , Enfermedades del Colágeno/patología , Edema/etiología , Fibrosis , Humanos , Hipertensión/complicaciones , Hipertensión/tratamiento farmacológico , Riñón/patología , Enfermedades Renales/diagnóstico , Enfermedades Renales/genética , Enfermedades Renales/patología , Glomérulos Renales/ultraestructura , Losartán/uso terapéutico , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Síndrome Nefrótico/patología , Proteinuria/etiología , Coloración y EtiquetadoRESUMEN
OBJECTIVES: This study aims to document the clinical features of patients with COL11A2 mutations and to describe the usefulness of massively parallel sequencing. METHODS: One thousand one hundred twenty (1120) Japanese hearing loss patients from 53 ENT departments nationwide participated in this study. Massively parallel sequencing of 63 genes implicated in hearing loss was performed to identify the genetic causes in the Japanese hearing loss patients. RESULTS: A novel mutation in COL11A2 (c.3937_3948delCCCCCAGGGCCA) was detected in an affected family, and it was segregated in all hearing loss individuals. The clinical findings of this family were compatible with non-ocular Stickler syndrome. Orofacial features of mid-facial hypoplasia and slowly progressive mild to moderate hearing loss were also presented. Audiological examinations showed favorable auditory performance with hearing aid(s). CONCLUSION: This is the first case report of the genetic diagnosis of a non-ocular Stickler syndrome family in the Japanese population. We suggest that it is important to take both genetic analysis data and clinical symptoms into consideration to make an accurate diagnosis.
Asunto(s)
Colágeno Tipo XI/genética , Pérdida Auditiva/genética , Secuenciación de Nucleótidos de Alto Rendimiento , Mutación Missense , Artritis , Niño , Enfermedades del Colágeno/genética , Enfermedades del Tejido Conjuntivo , Femenino , Mutación del Sistema de Lectura , Pérdida Auditiva Sensorineural , Humanos , Linaje , Fenotipo , Desprendimiento de RetinaRESUMEN
Stickler syndrome (SS) is a collagenopathy characterized by arthropathy and vitreoretinopathy with high myopia and cleft palate as common features. In a family with an autosomal recessive SS that does not map to genes known to cause autosomal recessive forms of SS, we combined autozygome and exome analysis to identify a novel missense variant in LOXL3 as the likely candidate cause. LOXL3 cross-links collagen II and its morphants phenocopy the craniofacial defects characteristic of collagen XI deficiency. We propose LOXL3 as a novel candidate gene for autosomal recessive SS.
Asunto(s)
Aminoácido Oxidorreductasas/genética , Mutación Missense , Adolescente , Secuencia de Aminoácidos , Artritis , Secuencia de Bases , Niño , Enfermedades del Colágeno/genética , Enfermedades del Tejido Conjuntivo , Consanguinidad , Familia , Femenino , Genes Recesivos , Pérdida Auditiva Sensorineural , Humanos , Masculino , Datos de Secuencia Molecular , Linaje , Desprendimiento de RetinaRESUMEN
PURPOSE: To study the variability of the ophthalmic phenotype in Kniest dysplasia. Kniest dysplasia is an inherited disorder associated with defects in type II collagen and characterised by short-trunked dwarfism, kyphoscoliosis, and enlarged joints with restricted mobility. Other features include marked hand arthropathy, cleft palate, hearing loss, and ocular abnormalities (myopia, abnormal vitreous, and high risk of developing retinal detachment). METHODS: Data from eight unrelated individuals with a clinical and molecular diagnosis of Kniest dysplasia are reported. Clinical assessment included an audiogram and ophthalmological examination in all but one patient who died in the immediate postnatal period. Sanger sequencing of the COL2A1 gene was performed. RESULTS: Six of the seven patients tested were high myopes with one patient being an emmetrope. Bilateral quandratic cataracts and subluxed lenses were noted in one subject. Variable but abnormal vitreous architecture was observed in all seven individuals tested. Six of the seven patients had significant hearing impairment and five of the seven patients exhibited clefting abnormalities. One patient had bilateral retinal detachments in his twenties. Six dominant disease-causing COL2A1 variants were detected. In three cases, testing of parental samples revealed that the disease-causing variant was not present in either parent. CONCLUSION: The ophthalmic features in Kniest dysplasia are very similar to those in other disorders of type II collagen such as Stickler syndrome. It is likely that different type II collagenopathies have a similar level of ocular morbidity and regular ophthalmologic examination is recommended. Kniest dysplasia is associated with heterozygous COL2A1 mutations that are frequently de novo.
Asunto(s)
Fisura del Paladar/genética , Enfermedades del Colágeno/genética , Colágeno Tipo II/genética , Enanismo/genética , Oftalmopatías/patología , Cara/anomalías , Enfermedad de la Membrana Hialina/genética , Osteocondrodisplasias/genética , Adolescente , Adulto , Niño , Preescolar , Fisura del Paladar/patología , Enfermedades del Colágeno/patología , Enanismo/patología , Oftalmopatías/etiología , Oftalmopatías/genética , Cara/patología , Femenino , Trastornos de la Audición/etiología , Humanos , Enfermedad de la Membrana Hialina/patología , Masculino , Mutación , Osteocondrodisplasias/patología , Fenotipo , Adulto JovenRESUMEN
INTRODUCTION: Stickler syndrome is caused by mutations in genes encoding type II and type XI collagens. About 85% of the pathogenic variants is found in COL2A1 (Stickler type 1), whereas a minority of mutations has been reported in COL11A1 (Stickler type 2) and COL11A2 (Stickler type 3). Beside the typical skeletal and orofacial manifestations, ocular anomalies are predominantly present in type 1 and type 2, while hearing loss is more pronounced in type 2 and type 3. METHODS: We performed COL11A1 mutation analysis for 40 type 2 Stickler patients and COL11A2 mutation analysis for five type 3 Stickler patients, previously all COL2A1 mutation-negative, using targeted next-generation sequencing (NGS) whereas whole-exome sequencing (WES) was performed in parallel for two patients. Three patients were analyzed for both genes due to unclear ocular findings. RESULTS: In total 14 COL11A1 and two COL11A2 mutations could be identified, seven of which are novel. Splice site alterations are the most frequent mutation type, followed by glycine substitutions. In addition, six variants of unknown significance (VUS) have been found. Identical mutations and variants were identified with both NGS techniques. CONCLUSION: We expand the mutation spectrum of COL11A1 and COL11A2 in Stickler syndrome patients and show that targeted NGS is an efficient and cost-effective molecular tool in the genetic diagnosis of Stickler syndrome, whereas the more standardized WES might be an alternative approach.
Asunto(s)
Colágeno Tipo XI/genética , Artritis , Enfermedades del Colágeno/genética , Enfermedades del Tejido Conjuntivo , Análisis Mutacional de ADN , Exoma , Estudios de Asociación Genética , Pérdida Auditiva Sensorineural , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Linaje , Desprendimiento de RetinaRESUMEN
BACKGROUND: Prednisolone is a potent anti-inflammatory glucocorticoid (GC) but chronic use is hampered by metabolic side effects. Little is known about the long-term effects of GCs on gene-expression in vivo during inflammation. AIM: Identify gene signatures underlying prednisolone-induced metabolic side effects in a complex in vivo inflammatory setting after long-term treatment. MATERIALS & METHODS: We performed whole-genome expression profiling in liver and muscle from arthritic and nonarthritic mice treated with several doses of prednisolone for 3 weeks and used text-mining to link gene signatures to metabolic pathways. RESULTS: Prednisolone-induced gene signatures were highly tissue specific. We identified a short-list of genes significantly affected by both prednisolone and inflammation in liver and involved in glucose and fatty acid metabolism. For several of these genes the association with GCs is novel. CONCLUSION: The identified gene signatures may provide useful starting points for the development of GCs with a better safety profile.
Asunto(s)
Antiinflamatorios/toxicidad , Enfermedades del Colágeno/genética , Enfermedades Metabólicas/genética , Prednisolona/toxicidad , Animales , Artritis/inducido químicamente , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Enfermedades del Colágeno/inducido químicamente , Enfermedades del Colágeno/metabolismo , Ácidos Grasos/metabolismo , Expresión Génica/efectos de los fármacos , Glucosa/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Enfermedades Metabólicas/inducido químicamente , Enfermedades Metabólicas/metabolismo , Ratones , Ratones Endogámicos CBA , Músculos/efectos de los fármacos , Músculos/metabolismoRESUMEN
The classification of bone dysplasia has relied on a clinical/radiographic interpretation and the identification of specific genetic alterations. The clinical presentation of the SOX9 mutation and type 2 collagen disorders overlap with the Pierre-Robin sequence and talipes equinovarus, but the former is often accompanied by the bent long bones. In its milder form, the SOX9 mutation is not necessarily associated with the bent long bones. Here, we report a patient with the Pierre-Robin sequence and talipes equinovarus who did not exhibit either bent long bones or scapular hypoplasia; thus, this patient was instead classified as having a type 2 collagen disorder. Despite this phenotypic presentation, the proposita was found to have a de novo SOX9 mutation. The peculiar location of the mutation within the dimerization domain might account for the relatively mild phenotypic effect of the SOX9 mutation to a degree that is compatible with a clinical diagnosis of type 2 collagen disorder, except for a developmental delay. We concluded that mutations in SOX9 can mimic a type 2 collagen disorder-like phenotype.